$OMIC
Singular Genomics Systems, Inc.

2022 Q1 Form 10-Q Financial Statement

#000095017022008982 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $11.38M $10.22M $3.654M
YoY Change 211.3% 62.53% 164.78%
% of Gross Profit
Research & Development $10.65M $9.455M $6.608M
YoY Change 61.09% 62.46% 63.97%
% of Gross Profit
Depreciation & Amortization $461.0K $364.0K $211.0K
YoY Change 118.48% 82.91% 62.31%
% of Gross Profit
Operating Expenses $22.02M $19.67M $10.26M
YoY Change 114.58% -28.55% 90.04%
Operating Profit -$22.02M -$10.26M
YoY Change 114.58%
Interest Expense $142.0K -$87.00K $188.0K
YoY Change -24.47% -59.15% 25.33%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$2.200M
YoY Change -100.0% -100.0%
Pretax Income -$22.01M -$19.76M -$23.92M
YoY Change -8.0% -29.29% 355.62%
Income Tax
% Of Pretax Income
Net Earnings -$22.01M -$19.76M -$23.92M
YoY Change -8.01% -29.29% 249.36%
Net Earnings / Revenue
Basic Earnings Per Share -$0.31
Diluted Earnings Per Share -$309.9K -$272.8K -$344.8K
COMMON SHARES
Basic Shares Outstanding 70.59M 72.06M
Diluted Shares Outstanding 71.01M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $316.0M $339.2M $150.1M
YoY Change 110.51%
Cash & Equivalents $188.6M $201.0M $46.01M
Short-Term Investments $127.4M $138.2M $104.6M
Other Short-Term Assets $3.486M $8.537M $1.400M
YoY Change 149.0%
Inventory $6.329M $3.011M
Prepaid Expenses $2.289M $3.715M
Receivables
Other Receivables
Total Short-Term Assets $325.8M $347.8M $151.5M
YoY Change 115.04% 1161.33%
LONG-TERM ASSETS
Property, Plant & Equipment $6.714M $6.072M $2.800M
YoY Change 139.79% 156.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.125M $1.129M $1.400M
YoY Change 51.79% 1293.83%
Total Long-Term Assets $16.32M $7.888M $4.100M
YoY Change 298.1% 169.12%
TOTAL ASSETS
Total Short-Term Assets $325.8M $347.8M $151.5M
Total Long-Term Assets $16.32M $7.888M $4.100M
Total Assets $342.1M $355.6M $155.6M
YoY Change 119.87% 1065.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.525M $2.348M $700.0K
YoY Change 403.57% 449.88%
Accrued Expenses $2.911M $4.278M $2.200M
YoY Change 32.32% 168.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.200M
YoY Change -100.0%
Total Short-Term Liabilities $9.082M $6.744M $7.900M
YoY Change 14.96% 82.76%
LONG-TERM LIABILITIES
Long-Term Debt $9.941M $9.904M $149.2M
YoY Change -93.34% 16.94%
Other Long-Term Liabilities $1.728M $2.827M $2.700M
YoY Change -36.0% 295.94%
Total Long-Term Liabilities $11.67M $12.73M $151.9M
YoY Change -92.32% 38.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.082M $6.744M $7.900M
Total Long-Term Liabilities $11.67M $12.73M $151.9M
Total Liabilities $24.63M $19.48M $159.8M
YoY Change -84.59% 51.29%
SHAREHOLDERS EQUITY
Retained Earnings -$173.9M -$151.9M
YoY Change 186.06%
Common Stock $7.000K $7.000K
YoY Change 600.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $317.5M $336.2M -$73.34M
YoY Change
Total Liabilities & Shareholders Equity $342.1M $355.6M $155.6M
YoY Change 119.87% 1065.98%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$22.01M -$19.76M -$23.92M
YoY Change -8.01% -29.29% 249.36%
Depreciation, Depletion And Amortization $461.0K $364.0K $211.0K
YoY Change 118.48% 82.91% 62.31%
Cash From Operating Activities -$19.84M -$15.70M -$9.185M
YoY Change 115.99% 124.82% 95.01%
INVESTING ACTIVITIES
Capital Expenditures $939.0K -$1.770M $507.0K
YoY Change 85.21% 646.84% -295.0%
Acquisitions
YoY Change
Other Investing Activities $9.325M -$21.56M -$89.95M
YoY Change -110.37% -372.95% -3481.58%
Cash From Investing Activities $8.386M -$23.32M -$90.46M
YoY Change -109.27% -404.5% -3869.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $23.00K $2.984M
YoY Change -99.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.00K 810.0K 133.5M
YoY Change -99.98% 2354.55% 1677.42%
NET CHANGE
Cash From Operating Activities -19.84M -15.70M -9.185M
Cash From Investing Activities 8.386M -23.32M -90.46M
Cash From Financing Activities 23.00K 810.0K 133.5M
Net Change In Cash -11.43M -38.21M 33.84M
YoY Change -133.78% -5482.25% 550.73%
FREE CASH FLOW
Cash From Operating Activities -$19.84M -$15.70M -$9.185M
Capital Expenditures $939.0K -$1.770M $507.0K
Free Cash Flow -$20.78M -$13.93M -$9.692M
YoY Change 114.38% 106.48% 117.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001850906
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40443
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
SINGULAR GENOMICS SYSTEMS, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2948451
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3010 Science Park Road
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2022Q1 dei City Area Code
CityAreaCode
858
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
333-7830
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
OMIC
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
70585264
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188572000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201049000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
127402000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
138174000
CY2022Q1 us-gaap Inventory Net
InventoryNet
6329000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3011000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3486000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5526000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
325789000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
347760000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5749000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6714000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6072000
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1734000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
687000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2125000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1129000
CY2022Q1 us-gaap Assets
Assets
342111000
CY2021Q4 us-gaap Assets
Assets
355648000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3525000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2348000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2911000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4278000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2646000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
118000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9082000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6744000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9941000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9904000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3878000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1728000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2827000
CY2022Q1 us-gaap Liabilities
Liabilities
24629000
CY2021Q4 us-gaap Liabilities
Liabilities
19475000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70509463
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72438742
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
492144000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
488200000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-767000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-138000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173902000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151896000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
317482000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
336173000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
342111000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
355648000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10645000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6608000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11375000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3654000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
22020000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
10262000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22020000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10262000
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
156000
CY2021Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
131000
CY2022Q1 us-gaap Interest Expense
InterestExpense
142000
CY2021Q1 us-gaap Interest Expense
InterestExpense
188000
CY2022Q1 omic Fair Value Adjustment Of Convertible Promissory Notes
FairValueAdjustmentOfConvertiblePromissoryNotes
0
CY2021Q1 omic Fair Value Adjustment Of Convertible Promissory Notes
FairValueAdjustmentOfConvertiblePromissoryNotes
11400000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2202000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22006000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-23921000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.05
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71011041
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11652998
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22006000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-23921000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-629000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-49000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22635000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23970000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
336173000
CY2022Q1 omic Vesting Of Common Stock Issued For Early Exercise Of Stock Options
VestingOfCommonStockIssuedForEarlyExerciseOfStockOptions
344000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3566000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-629000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22006000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
317482000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-51555000
CY2021Q1 omic Vesting Of Common Stock Issued For Early Exercise Of Stock Options
VestingOfCommonStockIssuedForEarlyExerciseOfStockOptions
92000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
995000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1096000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-49000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-23921000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-73342000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-22006000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-23921000
CY2022Q1 us-gaap Depreciation
Depreciation
461000
CY2021Q1 us-gaap Depreciation
Depreciation
211000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3566000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1096000
CY2022Q1 omic Fair Value Adjustment Of Convertible Promissory Notes
FairValueAdjustmentOfConvertiblePromissoryNotes
0
CY2021Q1 omic Fair Value Adjustment Of Convertible Promissory Notes
FairValueAdjustmentOfConvertiblePromissoryNotes
11400000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2202000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1174000
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
72000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
641000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
37000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
78000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3318000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1648000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
264000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1111000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
804000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1013000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
144000
CY2022Q1 omic Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-1367000
CY2021Q1 omic Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
585000
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-58000
CY2022Q1 omic Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-550000
CY2021Q1 omic Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
0
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-27000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
74000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19839000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9185000
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
35193000
CY2021Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
101608000
CY2022Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
10334000
CY2021Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
8838000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
34184000
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
2816000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
939000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
507000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8386000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90461000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2984000
CY2022Q1 omic Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
0
CY2021Q1 omic Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
130500000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133484000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11430000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33838000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201736000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12170000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190306000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46008000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
105000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
148000
CY2022Q1 omic Initial Lease Liability Recognized Upon Adoption Of Asc842
InitialLeaseLiabilityRecognizedUponAdoptionOfAsc842
7074000
CY2021Q1 omic Initial Lease Liability Recognized Upon Adoption Of Asc842
InitialLeaseLiabilityRecognizedUponAdoptionOfAsc842
0
CY2022Q1 omic Vesting Of Restricted Stock
VestingOfRestrictedStock
344000
CY2021Q1 omic Vesting Of Restricted Stock
VestingOfRestrictedStock
92000
CY2022Q1 omic Deferred Offering Costs In Accrued Expenses
DeferredOfferingCostsInAccruedExpenses
0
CY2021Q1 omic Deferred Offering Costs In Accrued Expenses
DeferredOfferingCostsInAccruedExpenses
804000
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
164000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
86000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173900000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151900000
CY2022Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
316000000.0
CY2022Q1 omic Period Of Operations Sufficient To Fund
PeriodOfOperationsSufficientToFund
P12M
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188572000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201049000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1734000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
687000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190306000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201736000
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
128169000
CY2022Q1 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-767000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
127402000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
138312000
CY2021Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-138000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
138174000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
99110000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
94085000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
28292000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
44089000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
127402000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
138174000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7100000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6400000
CY2022Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
700000
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
5034000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2565000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1295000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
446000
CY2022Q1 us-gaap Inventory Net
InventoryNet
6329000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3011000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2289000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3715000
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
694000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
1050000
CY2022Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
503000
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
761000
CY2022Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3486000
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
5526000
CY2022Q1 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
5 years or less
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9362000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8259000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2648000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2187000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6714000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6072000
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2180000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3516000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
281000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
200000
CY2022Q1 omic Accrued Contracted Research Costs Current
AccruedContractedResearchCostsCurrent
39000
CY2021Q4 omic Accrued Contracted Research Costs Current
AccruedContractedResearchCostsCurrent
41000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
411000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
521000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2911000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4278000
CY2019Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-09-01
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0065
omic Debt Instrument Interest Rate Due On Maturity Date
DebtInstrumentInterestRateDueOnMaturityDate
0.0550
CY2021Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
15000000.0
CY2022Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-09-01
CY2022Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
600000
CY2022Q1 us-gaap Security Deposit
SecurityDeposit
1100000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2022Q1 omic Debt Instrument Interest Rate Due On Maturity Date
DebtInstrumentInterestRateDueOnMaturityDate
0.0400
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
600000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10500000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10500000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
559000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
596000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
9941000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
9904000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
340000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
452000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2194000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5523000
CY2022Q1 omic Longtermdebtmaturitiesrepaymentsofprincipalinyearthreeandthereafter
Longtermdebtmaturitiesrepaymentsofprincipalinyearthreeandthereafter
3976000
CY2022Q1 omic Long Term Debt Maturities Repayments Of Principal Including Interest Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestPayments
12486000
CY2022Q1 omic Interest And Final Payment Fee
InterestAndFinalPaymentFee
-1986000
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10500000
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
559000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
9941000
CY2022Q1 omic Initial Lease Term
InitialLeaseTerm
P144M
CY2022Q1 us-gaap Lessor Operating Lease Renewal Term
LessorOperatingLeaseRenewalTerm
P60M
CY2022Q1 us-gaap Net Rentable Area
NetRentableArea
64.80
CY2022Q1 omic Annual Increases Percentage
AnnualIncreasesPercentage
0.03
CY2022Q1 omic Maximum Tenant Improvement Amount
MaximumTenantImprovementAmount
33000000
CY2022Q1 omic Tenant Improvements Amount
TenantImprovementsAmount
24000
CY2022Q1 omic Improvements Interest Rate
ImprovementsInterestRate
0.07
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
1100000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036
CY2022Q1 omic Cash Payments
CashPayments
7500000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036
CY2022Q1 omic Cash Payments
CashPayments
6800000
CY2022Q1 us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
1100000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2022Q1 omic Lessee Operating Lease Liability Payments Due Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsDueRemainderOfFiscalYear
1987000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2817000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1328000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
438000
CY2022Q1 omic Lessee Operating Lease Liability Payments Due Year Four And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter
277000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6847000
CY2022Q1 omic Operating Lease Future Minimum Payments Less Discount
OperatingLeaseFutureMinimumPaymentsLessDiscount
-323000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
6524000
CY2022Q1 omic Less Current Portion
LessCurrentPortion
2646000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3878000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
230900000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
3919000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
6892000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
6394000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
10914000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling After Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
210058000
CY2022Q1 omic Future Minimum Payments Total
FutureMinimumPaymentsTotal
238177000
CY2022Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
0.0001
CY2022Q1 omic Percentage Of Amended Shares Of Common Stock
PercentageOfAmendedSharesOfCommonStock
0.049
CY2022Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
38826388
CY2022Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
39020122
CY2022Q1 omic Temporary Equity Share Issued
TemporaryEquityShareIssued
38826388
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
38826388
CY2022Q1 omic Aggregate Liquidation Preference
AggregateLiquidationPreference
69500000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
The number of shares of common stock reserved for issuance under the 2021 Plan are increased automatically on the first business day of each fiscal year, commencing in 2022 and ending in 2031, by a number equal to the lesser of: (i) 5% of the shares of common stock outstanding on the last business day of the prior fiscal year; or (ii) the number of shares determined by the Company’s Board of Directors.
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5322314
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.75
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3296183
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.03
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4001890
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.56
CY2022Q1 omic Number Of Early Exercise Stock Option Remain Subject To Repurchase
NumberOfEarlyExerciseStockOptionRemainSubjectToRepurchase
1677569
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
65399
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.62
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
119461
CY2022Q1 omic Share Based Compensation Arrangements By Share Based Payment Award Options Forfeited In Period Weighted Average Forfeiture Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageForfeiturePrice
17.83
CY2021Q4 omic Number Of Early Exercise Stock Option Remain Subject To Repurchase
NumberOfEarlyExerciseStockOptionRemainSubjectToRepurchase
2198933
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9139344
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.00
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3365635
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.08
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y9M21D
CY2022Q1 omic Liability For Cash Received From Early Exercise Of Stock
LiabilityForCashReceivedFromEarlyExerciseOfStock
1300000
CY2021Q4 omic Liability For Cash Received From Early Exercise Of Stock
LiabilityForCashReceivedFromEarlyExerciseOfStock
1700000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3566000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1096000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
44300000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5687
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8250
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0167
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0087
CY2022Q1 omic Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0000
CY2021Q1 omic Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0000
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
17540842
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13316913
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46643533

Files In Submission

Name View Source Status
0000950170-22-008982-index-headers.html Edgar Link pending
0000950170-22-008982-index.html Edgar Link pending
0000950170-22-008982.txt Edgar Link pending
0000950170-22-008982-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
omic-20220331.htm Edgar Link pending
omic-20220331.xsd Edgar Link pending
omic-20220331_cal.xml Edgar Link unprocessable
omic-20220331_def.xml Edgar Link unprocessable
omic-20220331_htm.xml Edgar Link completed
omic-20220331_lab.xml Edgar Link unprocessable
omic-20220331_pre.xml Edgar Link unprocessable
omic-ex10_1.htm Edgar Link pending
omic-ex31_1.htm Edgar Link pending
omic-ex31_2.htm Edgar Link pending
omic-ex32_1.htm Edgar Link pending
omic-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending